![]() Silverman estimated that without companies transferring their knowledge of how to make COVID-19 vaccines, it would take manufacturers elsewhere double the time needed to start making doses, noting that billions of vaccines against other diseases are routinely made in developing countries. “We desperately need the companies who have a monopoly over the COVID vaccines to transfer their technology, and we need the U.S. ![]() “What the world really needs is distributed regional manufacturing capacity of vaccines, and it sounds like this investment is focused on building U.S. Robbie Silverman, senior advocacy manager at Oxfam America, welcomed Biden’s plan to invest into vaccine manufacturing capacity but said it was nowhere near sufficient. The Pfizer and Moderna vaccines are made with a piece of genetic code called messenger RNA that tells the body to make harmless copies of the spike protein so it’s trained to recognize the virus. The administration is prioritizing the mRNA vaccines, which have proven to be more effective against preventing serious illness and death from COVID-19 than the Johnson & Johnson viral vector vaccine, which uses a harmless virus that carries genetic material to stimulate the immune system. ![]() on the investment, but the Biden administration hopes that the enhanced manufacturing capacity, through support for the company’s facilities, equipment, staff or training, will by mid-2022 allow more COVID-19 doses to be shared overseas as well as help prepare for the next public health emergency. There are no firm agreements yet with Moderna or Pfizer to take up the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |